ACIP Recommendations for the Use of Influenza Vaccines During the 2017-18 Season

August 31, 2017

On August 25, 2017, the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) recommended that all persons 6 months and older receive an annual influenza vaccination for the prevention and control of influenza. For the 2017-18 season, quadrivalent and trivalent influenza vaccines are available. Updates to the recommendations reflect discussions during public meetings of ACIP held on October 20, 2016; February 22, 2017; and June 21, 2017.
Read more»

The latest updates include the following:

  • Vaccine viruses included in the 2017-18 U.S. trivalent influenza vaccines will be an A/Michigan/45/2015 (H1N1)pdm09-like virus, an A/Hong Kong/4801/2014 (H3N2)-like virus, and a B/Brisbane/60/2008-like virus (Victoria lineage). Quadrivalent influenza vaccines will contain these three viruses and an additional influenza B vaccine virus, a B/Phuket/3073/2013-like virus (Yamagata lineage).
  • Information on recent licensures and labeling changes is discussed, including licensure of Afluria Quadrivalent (IIV4; Seqirus, Parkville, Victoria, Australia); Flublok Quadrivalent (RIV4; Protein Sciences, Meriden, Connecticut); and expansion of the age indication for FluLaval Quadrivalent (IIV4; ID Biomedical Corporation of Quebec, Quebec City, Quebec, Canada), previously licensed for 3 years and older, to 6 months and older.
  • Pregnant women may receive any licensed, recommended, age-appropriate influenza vaccine.
  • Afluria (IIV3; Seqirus, Parkville, Victoria, Australia) may be used for persons aged 5 years and older, consistent with Food and Drug Administration-approved labeling.
  • FluMist Quadrivalent (LAIV4; MedImmune, Gaithersburg, Maryland) should not be used during the 2017-18 season due to concerns about it effectiveness against influenza A(H1N1)pdm09 viruses in the United States during the 2013-14 and 2015-16 influenza seasons.

Be Prepared This Season

With MyFluVaccine, you can select from our comprehensive products portfolio and choose your preferred delivery date(s). As always, to give you more flexibility, we recommend that you split your order(s) among multiple presentations and manufacturers.

Flu Vaccine Availability
Fluvirin 5 mL SOLD OUT
Fluvirin 0.5 mL PFS SOLD OUT
Afluria 5 mL MDV SOLD OUT
Afluria 0.5 mL PFS SOLD OUT
Fluad 0.5 mL PFS ORDER NOW
Afluria Quad 5 mL MDV SOLD OUT
Afluria Quad 0.5 mL PFS SOLD OUT
Flucelvax Quad 5 mL MDV ORDER NOW
Flucelvax Quad 0.5 mL PFS ORDER NOW
Fluzone Quad 5 mL MDV SOLD OUT
Fluzone Quad 0.25 mL PFS ORDER NOW
Fluzone Quad 0.5 mL PFS ORDER NOW
Fluzone Quad 0.5 mL SDV ORDER NOW
Fluzone High-Dose 0.5 mL PFS ORDER NOW
Fluzone Intradermal Quad 0.1 mL PFS ORDER NOW
FluLaval Quad 5 mL MDV SOLD OUT
Fluarix Quad 0.5 mL PFS SOLD OUT
FluMist Quad 0.2 mL PFS ORDER NOW
Flublok Quad 0.5 mL PFS ORDER NOW